Nifty

:

24971.90

Sensex

:

81896.79

-140.50 (-0.56%)
-511.38 (-0.62%)

Login

Nifty
Sensex

:
:

24971.90
81896.79

-140.50 (-0.56%)
-511.38 (-0.62%)

Wockhardt Ltd.

Pharmaceuticals & Drugs - Global

Rating :

57/99

BSE: 532300 | NSE: WOCKPHARMA

Watchlist

NSE BSE

1752.10

23-Jun-2025

Open
High
Low
Previous Close

1710
1765
1705.7
1730.80

Volume
Traded Value (lacs)
52 Week High
52 Week Low

577851
1005098295.5
1868.8
578.3

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

28,471.53
N/A
5

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

30,139.53
N/A
6.54

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-4.60
-3.39
-4.67

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-25.18
-30.65
-33.42

PAT CAGR (%)

10 Years
5 Years
3 Years

-
46.24
23.80

P:E (Median)

8 Years
5 Years
3 Years

-
-
-

P:BV (Average)

8 Years
5 Years
3 Years

2.03
2.08
2.53

EV:EBITDA (Average)

8 Years
5 Years
3 Years

67.14
46.52
49.52

Earnings Forecasts:

(Updated: 06-06-2025)

Description 2024 2025 2026 2027
Adj EPS -32.1 -3.02 17 44
P/E Ratio -54.58 -580.17 103.06 39.82
Revenue 2789 3012 5355 5799
EBITDA 39 1388 1328
Net Income -463 -47 238 638
ROA -6
P/B Ratio 14.96
ROE -13.79
FCFF -34
FCFF Yield -0.14
Net Debt 1827
BVPS 117.08

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var%
Net Sales 355.00 355.00 0.00% 325.00 288.00 12.85% 370.00 260.00 42.31% 352.00 251.00 40.24%
Expenses 249.00 401.00 -37.91% 263.00 263.00 0.00% 321.00 270.00 18.89% 272.00 256.00 6.25%
EBITDA 106.00 -46.00 - 62.00 25.00 148.00% 49.00 -10.00 - 80.00 -5.00 -
EBIDTM 29.86% -12.96% 19.08% 8.68% 13.24% -3.85% 22.73% -1.99%
Other Income 14.00 24.00 -41.67% 6.00 5.00 20.00% 11.00 6.00 83.33% 27.00 6.00 350.00%
Interest 40.00 59.00 -32.20% 48.00 61.00 -21.31% 53.00 59.00 -10.17% 58.00 58.00 0.00%
Depreciation 40.00 45.00 -11.11% 42.00 43.00 -2.33% 43.00 44.00 -2.27% 43.00 44.00 -2.27%
PBT 40.00 -126.00 - -22.00 -74.00 - -36.00 -107.00 - 6.00 -115.00 -
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 40.00 -126.00 - -22.00 -74.00 - -36.00 -107.00 - 6.00 -115.00 -
PATM 11.27% -35.49% -6.77% -25.69% -9.73% -41.15% 1.70% -45.82%
EPS 2.46 -7.75 - -1.35 -4.55 - -2.22 -6.58 - 0.37 -7.08 -

Description Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var%
Net Sales 743.00 700.00 6.14% 721.00 701.00 2.85% 809.00 753.00 7.44% 739.00 644.00 14.75%
Expenses 679.00 803.00 -15.44% 593.00 664.00 -10.69% 699.00 681.00 2.64% 648.00 628.00 3.18%
EBITDA 64.00 -103.00 - 128.00 37.00 245.95% 110.00 72.00 52.78% 91.00 16.00 468.75%
EBIDTM 8.61% -14.71% 17.75% 5.28% 13.60% 9.56% 12.31% 2.48%
Other Income 15.00 54.00 -72.22% 8.00 8.00 0.00% 9.00 24.00 -62.50% 30.00 14.00 114.29%
Interest 48.00 73.00 -34.25% 60.00 77.00 -22.08% 73.00 76.00 -3.95% 73.00 79.00 -7.59%
Depreciation 53.00 58.00 -8.62% 55.00 55.00 0.00% 55.00 55.00 0.00% 54.00 55.00 -1.82%
PBT -22.00 -180.00 - 21.00 -87.00 - -9.00 -35.00 - -6.00 -118.00 -
Tax 23.00 -3.00 - 1.00 -1.00 - 7.00 38.00 -81.58% 10.00 18.00 -44.44%
PAT -45.00 -177.00 - 20.00 -86.00 - -16.00 -73.00 - -16.00 -136.00 -
PATM -6.06% -25.29% 2.77% -12.27% -1.98% -9.69% -2.17% -21.12%
EPS -1.54 -10.97 - 0.86 -5.76 - -1.43 -5.35 - -0.91 -9.31 -

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 1,402.00 1,154.00 1,072.00 1,372.00 987.00 1,371.22 2,149.95 2,477.29 2,297.52 2,216.53 1,886.55 Net Sales Growth 21.49% 7.65% -21.87% 39.01% -28.02% -36.22% -13.21% 7.82% 3.65% 17.49% Cost Of Goods Sold 436.00 461.00 401.00 476.00 416.00 313.29 693.92 975.36 949.56 905.63 796.88 Gross Profit 966.00 693.00 671.00 896.00 571.00 1,057.93 1,456.03 1,501.93 1,347.96 1,310.90 1,089.67 GP Margin 68.90% 60.05% 62.59% 65.31% 57.85% 77.15% 67.72% 60.63% 58.67% 59.14% 57.76% Total Expenditure 1,105.00 1,190.00 1,002.00 1,150.00 1,125.00 1,401.80 2,069.48 2,154.40 2,164.07 2,090.61 1,879.12 Power & Fuel Cost - 68.00 54.00 62.00 55.00 61.02 66.34 55.91 83.31 86.97 75.74 % Of Sales - 5.89% 5.04% 4.52% 5.57% 4.45% 3.09% 2.26% 3.63% 3.92% 4.01% Employee Cost - 247.00 240.00 261.00 293.00 325.46 345.69 506.44 523.22 473.73 409.62 % Of Sales - 21.40% 22.39% 19.02% 29.69% 23.74% 16.08% 20.44% 22.77% 21.37% 21.71% Manufacturing Exp. - 95.00 91.00 111.00 100.00 69.69 108.02 99.61 138.04 149.79 161.27 % Of Sales - 8.23% 8.49% 8.09% 10.13% 5.08% 5.02% 4.02% 6.01% 6.76% 8.55% General & Admin Exp. - 111.00 105.00 106.00 106.00 141.75 209.01 228.47 201.10 220.67 172.85 % Of Sales - 9.62% 9.79% 7.73% 10.74% 10.34% 9.72% 9.22% 8.75% 9.96% 9.16% Selling & Distn. Exp. - 41.00 43.00 57.00 44.00 42.69 61.09 130.69 130.86 113.91 105.26 % Of Sales - 3.55% 4.01% 4.15% 4.46% 3.11% 2.84% 5.28% 5.70% 5.14% 5.58% Miscellaneous Exp. - 167.00 68.00 77.00 111.00 447.90 585.41 157.92 137.98 139.91 105.26 % Of Sales - 14.47% 6.34% 5.61% 11.25% 32.66% 27.23% 6.37% 6.01% 6.31% 8.35% EBITDA 297.00 -36.00 70.00 222.00 -138.00 -30.58 80.47 322.89 133.45 125.92 7.43 EBITDA Margin 21.18% -3.12% 6.53% 16.18% -13.98% -2.23% 3.74% 13.03% 5.81% 5.68% 0.39% Other Income 58.00 41.00 67.00 38.00 41.00 85.82 34.80 56.85 259.71 61.50 465.11 Interest 199.00 237.00 229.00 273.00 200.00 220.17 170.88 169.58 168.72 107.86 19.18 Depreciation 168.00 176.00 186.00 171.00 184.00 173.39 119.82 106.24 105.66 99.08 102.93 PBT -12.00 -408.00 -278.00 -184.00 -481.00 -338.32 -175.43 103.92 118.78 -19.52 350.43 Tax 0.00 0.00 -47.00 -44.00 -231.00 -107.20 -93.54 35.26 -18.34 -27.86 18.61 Tax Rate 0.00% 0.00% 9.16% 23.91% 37.08% 31.69% 53.32% 33.93% -15.44% 142.73% 5.31% PAT -12.00 -422.00 -466.00 -140.00 -392.00 -231.12 -81.89 68.66 137.12 8.34 331.82 PAT before Minority Interest -12.00 -422.00 -466.00 -140.00 -392.00 -231.12 -81.89 68.66 137.12 8.34 331.82 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin -0.86% -36.57% -43.47% -10.20% -39.72% -16.86% -3.81% 2.77% 5.97% 0.38% 17.59% PAT Growth 0.00% - - - - - - -49.93% 1,544.12% -97.49% EPS -0.74 -25.97 -28.68 -8.62 -24.12 -14.22 -5.04 4.23 8.44 0.51 20.42

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 3,012.00 2,798.00 2,651.00 3,230.00 2,708.00 3,325.15 4,158.38 3,936.90 4,014.61 4,453.22 4,481.54 Net Sales Growth 7.65% 5.55% -17.93% 19.28% -18.56% -20.04% 5.63% -1.94% -9.85% -0.63% Cost Of Goods Sold 1,132.00 1,165.00 1,111.00 1,267.00 1,135.00 1,203.45 1,636.31 1,797.53 1,662.07 1,613.68 1,487.48 Gross Profit 1,880.00 1,633.00 1,540.00 1,963.00 1,573.00 2,121.70 2,522.07 2,139.37 2,352.54 2,839.54 2,994.06 GP Margin 62.42% 58.36% 58.09% 60.77% 58.09% 63.81% 60.65% 54.34% 58.60% 63.76% 66.81% Total Expenditure 2,619.00 2,759.00 2,550.00 2,932.00 2,771.00 3,082.03 4,050.63 3,935.07 3,988.39 3,958.98 3,772.14 Power & Fuel Cost - 107.00 103.00 98.00 82.00 85.41 93.30 77.80 110.10 113.99 101.40 % Of Sales - 3.82% 3.89% 3.03% 3.03% 2.57% 2.24% 1.98% 2.74% 2.56% 2.26% Employee Cost - 629.00 637.00 749.00 763.00 743.33 800.38 937.06 966.51 950.77 868.87 % Of Sales - 22.48% 24.03% 23.19% 28.18% 22.35% 19.25% 23.80% 24.07% 21.35% 19.39% Manufacturing Exp. - 142.00 126.00 169.00 145.00 120.90 153.76 135.27 179.40 228.07 236.03 % Of Sales - 5.08% 4.75% 5.23% 5.35% 3.64% 3.70% 3.44% 4.47% 5.12% 5.27% General & Admin Exp. - 188.00 192.00 224.00 251.00 186.55 380.13 476.66 504.43 405.85 320.92 % Of Sales - 6.72% 7.24% 6.93% 9.27% 5.61% 9.14% 12.11% 12.56% 9.11% 7.16% Selling & Distn. Exp. - 125.00 134.00 180.00 132.00 141.18 176.22 208.89 205.30 241.11 261.55 % Of Sales - 4.47% 5.05% 5.57% 4.87% 4.25% 4.24% 5.31% 5.11% 5.41% 5.84% Miscellaneous Exp. - 403.00 247.00 245.00 263.00 601.21 810.53 301.86 360.58 405.51 261.55 % Of Sales - 14.40% 9.32% 7.59% 9.71% 18.08% 19.49% 7.67% 8.98% 9.11% 11.07% EBITDA 393.00 39.00 101.00 298.00 -63.00 243.12 107.75 1.83 26.22 494.24 709.40 EBITDA Margin 13.05% 1.39% 3.81% 9.23% -2.33% 7.31% 2.59% 0.05% 0.65% 11.10% 15.83% Other Income 62.00 83.00 122.00 20.00 132.00 60.08 21.02 120.23 100.83 66.10 66.55 Interest 254.00 305.00 302.00 299.00 249.00 275.74 265.14 255.49 225.27 128.96 55.21 Depreciation 217.00 223.00 251.00 247.00 246.00 224.14 163.95 149.53 148.93 141.91 145.40 PBT -16.00 -406.00 -330.00 -228.00 -426.00 -196.68 -300.32 -282.96 -247.15 289.47 575.34 Tax 41.00 52.00 -3.00 -132.00 -271.00 -153.29 -83.66 25.70 -21.11 37.88 162.65 Tax Rate -256.25% -12.38% 0.48% 32.12% 47.71% 77.94% 27.86% -4.01% 8.54% 13.09% 28.27% PAT -57.00 -463.00 -559.00 -244.00 -299.00 -69.22 -194.53 -608.30 -195.72 250.08 404.91 PAT before Minority Interest -47.00 -472.00 -621.00 -279.00 -297.00 -43.39 -216.66 -666.85 -226.04 251.59 412.69 Minority Interest 10.00 9.00 62.00 35.00 -2.00 -25.83 22.13 58.55 30.32 -1.51 -7.78 PAT Margin -1.89% -16.55% -21.09% -7.55% -11.04% -2.08% -4.68% -15.45% -4.88% 5.62% 9.04% PAT Growth 0.00% - - - - - - - - -38.24% EPS -3.51 -28.49 -34.40 -15.02 -18.40 -4.26 -11.97 -37.43 -12.04 15.39 24.92

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 1,796.00 1,753.00 2,212.00 1,606.00 994.62 1,226.63 1,294.69 1,219.32 1,167.96 1,370.09 Share Capital 77.00 72.00 72.00 55.00 55.37 55.34 55.32 55.27 55.25 353.59 Total Reserves 1,706.00 1,665.00 2,122.00 1,523.00 909.28 1,139.02 1,202.65 1,127.04 1,084.06 970.39 Non-Current Liabilities 934.00 103.00 333.00 531.00 1,212.24 1,344.91 1,257.89 1,697.40 2,109.16 1,219.29 Secured Loans 0.00 10.00 51.00 257.00 516.04 703.71 753.12 979.46 1,159.58 563.14 Unsecured Loans 891.00 2.00 95.00 2.00 3.46 238.22 5.27 303.16 273.26 4.59 Long Term Provisions 28.00 26.00 32.00 33.00 32.10 44.26 53.12 46.13 38.58 519.96 Current Liabilities 1,888.00 2,626.00 3,049.00 2,603.00 2,305.25 1,827.74 1,789.03 1,594.02 1,293.15 2,046.03 Trade Payables 580.00 557.00 582.00 405.00 524.36 618.75 445.79 346.35 332.50 344.40 Other Current Liabilities 552.00 727.00 1,403.00 1,037.00 855.43 611.06 814.34 518.65 379.73 1,404.81 Short Term Borrowings 728.00 1,315.00 1,034.00 1,066.00 880.80 561.71 437.09 661.86 550.03 270.17 Short Term Provisions 28.00 27.00 30.00 95.00 44.66 36.22 91.81 67.16 30.89 26.65 Total Liabilities 4,618.00 4,482.00 5,594.00 4,740.00 4,512.11 4,399.28 4,341.61 4,510.74 4,570.27 4,635.41 Net Block 1,449.00 1,625.00 1,828.00 1,684.00 2,044.35 1,614.32 1,422.73 1,464.51 1,401.80 1,005.49 Gross Block 3,374.00 3,383.00 3,412.00 3,105.00 3,315.29 2,739.84 2,428.40 2,370.85 2,205.84 1,709.11 Accumulated Depreciation 1,925.00 1,758.00 1,584.00 1,421.00 1,270.94 1,125.52 1,005.67 906.34 804.04 703.62 Non Current Assets 2,839.00 3,007.00 3,206.00 2,901.00 2,905.56 2,569.34 2,674.49 2,713.97 2,548.92 3,062.83 Capital Work in Progress 833.00 823.00 825.00 716.00 305.29 380.90 653.34 665.34 663.60 792.16 Non Current Investment 297.00 297.00 297.00 297.00 297.27 297.27 297.22 297.22 297.22 297.22 Long Term Loans & Adv. 243.00 245.00 238.00 203.00 202.02 236.22 277.49 277.72 186.30 864.25 Other Non Current Assets 17.00 17.00 18.00 1.00 56.63 40.63 23.71 9.18 0.00 103.71 Current Assets 1,668.00 1,296.00 2,244.00 1,839.00 1,606.55 1,829.94 1,667.12 1,796.77 2,021.35 1,572.58 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 321.00 363.00 387.00 348.00 314.93 370.04 377.07 534.72 534.81 524.43 Sundry Debtors 566.00 551.00 1,292.00 955.00 939.66 1,005.01 799.76 342.83 270.56 209.70 Cash & Bank 486.00 37.00 207.00 138.00 157.48 226.21 252.73 659.78 835.39 678.49 Other Current Assets 295.00 75.00 69.00 206.00 194.48 228.68 237.56 259.44 380.59 159.96 Short Term Loans & Adv. 219.00 270.00 289.00 192.00 137.84 228.68 231.61 199.44 380.59 159.96 Net Current Assets -220.00 -1,330.00 -805.00 -764.00 -698.70 2.20 -121.91 202.75 728.20 -473.45 Total Assets 4,507.00 4,303.00 5,450.00 4,740.00 4,512.11 4,399.28 4,341.61 4,510.74 4,570.27 4,635.41

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 3,359.00 3,354.00 3,849.00 3,376.00 2,671.67 2,674.80 2,852.15 3,336.71 3,775.12 3,715.35 Share Capital 77.00 72.00 72.00 55.00 55.37 55.34 55.32 55.27 55.25 353.59 Total Reserves 3,269.00 3,266.00 3,759.00 3,293.00 2,586.33 2,587.19 2,760.11 3,244.43 3,691.22 3,315.65 Non-Current Liabilities 617.00 -22.00 261.00 496.00 1,194.85 1,702.75 2,088.89 3,151.38 1,893.49 1,872.46 Secured Loans 0.00 222.00 260.00 500.00 1,237.44 1,653.25 2,167.84 2,887.11 1,647.34 1,180.25 Unsecured Loans 891.00 2.00 95.00 3.00 3.46 238.22 5.27 303.16 273.26 4.59 Long Term Provisions 28.00 26.00 32.00 84.00 45.60 53.48 64.89 94.23 70.74 635.05 Current Liabilities 2,791.00 3,435.00 3,207.00 3,121.00 3,497.18 2,863.66 2,691.71 1,978.81 1,841.85 1,772.97 Trade Payables 766.00 867.00 921.00 696.00 895.27 840.24 601.78 533.81 637.69 552.56 Other Current Liabilities 1,144.00 1,172.00 1,197.00 1,230.00 1,579.80 1,353.09 1,548.13 690.13 621.23 844.44 Short Term Borrowings 832.00 1,330.00 1,034.00 1,066.00 903.86 561.71 437.09 662.80 550.03 348.28 Short Term Provisions 49.00 66.00 55.00 129.00 118.25 108.62 104.71 92.07 32.90 27.69 Total Liabilities 7,070.00 7,075.00 7,670.00 7,376.00 7,749.49 7,571.04 7,978.48 8,848.84 7,975.79 7,504.73 Net Block 2,881.00 3,042.00 3,462.00 3,343.00 3,502.29 3,057.93 2,887.96 2,772.55 2,808.70 2,122.74 Gross Block 5,721.00 5,696.00 6,019.00 5,656.00 6,703.28 6,112.89 5,772.29 5,456.40 4,377.01 4,552.96 Accumulated Depreciation 2,840.00 2,654.00 2,557.00 2,313.00 3,200.99 3,054.96 2,884.33 2,683.85 1,568.31 2,430.22 Non Current Assets 4,886.00 4,867.00 5,081.00 4,951.00 5,319.66 4,756.39 4,598.88 4,313.57 4,023.94 3,983.17 Capital Work in Progress 1,722.00 1,539.00 1,342.00 1,379.00 1,584.53 1,445.48 1,432.57 1,243.95 1,036.05 1,007.30 Non Current Investment 0.00 0.00 0.00 0.00 0.45 0.45 0.45 0.45 0.45 2.62 Long Term Loans & Adv. 266.00 269.00 259.00 228.00 230.63 252.37 277.90 296.62 178.74 845.68 Other Non Current Assets 17.00 17.00 18.00 1.00 1.76 0.16 0.00 0.00 0.00 4.83 Current Assets 2,073.00 1,914.00 2,445.00 2,425.00 2,429.83 2,814.65 3,379.60 4,535.27 3,951.85 3,521.56 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 213.25 562.27 0.00 338.72 Inventories 640.00 658.00 769.00 799.00 689.83 819.36 855.71 1,107.95 1,102.16 1,020.78 Sundry Debtors 618.00 797.00 918.00 918.00 1,242.69 1,273.90 962.45 1,034.45 1,111.42 741.43 Cash & Bank 529.00 124.00 406.00 292.00 268.46 448.65 1,082.25 1,603.61 1,478.11 1,234.55 Other Current Assets 286.00 0.00 0.00 144.00 228.85 272.74 265.94 226.99 260.16 186.08 Short Term Loans & Adv. 286.00 335.00 352.00 272.00 172.21 252.56 257.63 197.75 260.16 186.08 Net Current Assets -718.00 -1,521.00 -762.00 -696.00 -1,067.35 -49.01 687.89 2,556.46 2,110.00 1,748.59 Total Assets 6,959.00 6,781.00 7,526.00 7,376.00 7,749.49 7,571.04 7,978.48 8,848.84 7,975.79 7,504.73

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 188.00 71.00 -93.00 -563.00 221.51 58.33 119.38 -235.02 -363.18 -53.40 PBT -422.00 -513.00 -184.00 861.00 -338.32 -175.43 103.92 118.78 -19.52 350.43 Adjustment 494.00 433.00 410.00 -995.00 355.96 273.57 251.33 35.72 165.63 -295.25 Changes in Working Capital 116.00 156.00 -240.00 -318.00 204.37 -15.40 -225.82 -364.51 -505.34 -18.06 Cash after chg. in Working capital 188.00 76.00 -14.00 -452.00 222.01 82.74 129.43 -210.01 -359.23 37.12 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.00 -5.00 -79.00 -111.00 -0.50 -24.41 -10.05 -25.01 -3.95 -90.52 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -75.00 -3.00 -244.00 1,014.00 -16.15 120.33 450.74 368.91 -1,014.95 204.72 Net Fixed Assets -1.00 31.00 -416.00 -200.42 -499.84 -39.00 -45.55 -166.75 -368.17 -299.87 Net Investments 0.00 0.00 0.00 0.27 0.00 -0.05 0.00 0.00 0.00 10.73 Others -74.00 -34.00 172.00 1,214.15 483.69 159.38 496.29 535.66 -646.78 493.86 Cash from Financing Activity 346.00 -236.00 430.00 -480.00 -273.97 -69.42 -523.84 -133.06 763.89 424.91 Net Cash Inflow / Outflow 459.00 -168.00 93.00 -29.00 -68.61 109.24 46.28 0.83 -614.24 576.23 Opening Cash & Equivalents 4.00 172.00 79.00 108.00 177.07 67.83 21.56 20.81 636.48 61.63 Closing Cash & Equivalent 463.00 4.00 172.00 79.00 108.46 177.07 67.83 21.56 22.47 636.38

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 219.00 153.00 413.00 -287.00 648.96 183.32 68.44 -269.47 71.61 354.96 PBT -420.00 -624.00 -411.00 916.00 -196.68 -300.32 -641.15 -247.15 357.01 575.34 Adjustment 677.00 635.00 554.00 -943.00 483.23 444.52 448.78 303.04 201.29 285.63 Changes in Working Capital -8.00 153.00 367.00 -143.00 379.58 80.29 278.33 -297.39 -402.76 -344.62 Cash after chg. in Working capital 249.00 164.00 510.00 -170.00 666.13 224.49 85.96 -241.50 155.54 516.35 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -30.00 -11.00 -97.00 -117.00 -17.17 -41.17 -17.52 -27.97 -83.93 -161.39 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -137.00 -125.00 -201.00 1,470.00 -155.53 94.57 630.24 -686.64 -818.19 -206.63 Net Fixed Assets -1.00 31.00 -416.00 -200.42 -499.84 -39.00 -45.55 -166.75 -368.17 -299.87 Net Investments 0.00 0.00 0.00 0.27 0.00 -0.05 0.00 0.00 0.00 10.73 Others -136.00 -156.00 215.00 1,670.15 344.31 133.62 675.79 -519.89 -450.02 82.51 Cash from Financing Activity 334.00 -315.00 -71.00 -1,171.00 -679.58 -776.45 -769.47 1,254.49 254.26 -75.65 Net Cash Inflow / Outflow 416.00 -287.00 141.00 12.00 -186.15 -498.56 -70.79 298.38 -492.32 72.68 Opening Cash & Equivalents 90.00 370.00 232.00 219.00 397.34 897.24 963.64 662.98 1,158.69 1,101.65 Closing Cash & Equivalent 505.00 90.00 370.00 232.00 219.34 397.34 897.24 963.64 664.64 1,158.69

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 115.78 120.63 152.36 132.20 87.11 107.91 113.70 106.96 103.11 93.15 ROA -9.27% -9.25% -2.71% -8.47% -5.19% -1.87% 1.55% 3.02% 0.18% 7.87% ROE -23.98% -23.71% -7.42% -30.83% -21.41% -6.68% 5.63% 11.81% 0.77% 34.62% ROCE -5.32% -7.92% 2.54% -13.89% -3.95% -0.15% 8.54% 8.86% 3.29% 20.37% Fixed Asset Turnover 0.34 0.32 0.42 0.31 0.45 0.83 1.03 1.00 1.13 1.14 Receivable days 176.34 313.17 298.24 350.33 258.82 153.20 84.17 48.72 39.54 43.96 Inventory Days 107.98 127.44 97.55 122.58 91.16 63.42 67.17 84.96 87.21 97.25 Payable days 450.11 518.37 378.42 407.71 211.57 135.84 81.85 63.18 67.46 71.50 Cash Conversion Cycle -165.79 -77.76 17.37 65.20 138.42 80.78 69.50 70.51 59.29 69.71 Total Debt/Equity 1.00 0.93 0.72 1.02 1.94 1.58 1.41 1.79 1.74 0.63 Interest Cover -0.78 -1.24 0.33 -2.12 -0.54 -0.03 1.61 1.70 0.82 19.27

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 217.27 231.81 266.04 280.48 238.55 238.75 254.47 298.51 339.05 306.20 ROA -6.67% -8.42% -3.71% -3.93% -0.57% -2.79% -7.93% -2.69% 3.25% 6.09% ROE -14.12% -17.32% -7.77% -9.92% -1.64% -7.94% -21.81% -6.42% 7.07% 12.49% ROCE -2.15% -5.88% -1.96% -5.50% 1.32% -0.56% -5.47% -0.31% 6.87% 11.25% Fixed Asset Turnover 0.63 0.73 0.88 0.75 0.52 0.70 0.70 0.82 1.00 0.98 Receivable days 71.63 73.25 65.29 85.04 138.12 98.15 92.57 97.55 75.93 49.71 Inventory Days 65.71 60.95 55.76 58.60 82.83 73.51 91.03 100.47 87.00 81.88 Payable days 255.81 293.71 232.91 255.87 129.66 86.65 67.29 64.08 64.54 63.71 Cash Conversion Cycle -118.47 -159.51 -111.86 -112.23 91.29 85.01 116.31 133.94 98.39 67.88 Total Debt/Equity 0.63 0.57 0.49 0.70 1.22 1.28 1.33 1.26 0.71 0.55 Interest Cover -0.38 -1.07 -0.37 -1.28 0.29 -0.13 -1.51 -0.10 3.24 11.42

Top Investors:

rekha jhunjhunwala

tata mutual fund - tata small cap fund

3p india equity fund 1

hdfc large and mid cap fund

hsbc small cap fund

investor education and protection fund (iepf)

Annual Reports:

News Update:

Wockhardt eyeing to launch new antibiotic in second half of FY25-26
6th Jun 2025, 16:00 PM

The company is aiming $7 billion market opportunity in US and European market with this drug
Read More
Wockhardt’s arm incorporates Wholly Owned Subsidiary in Ireland
9th Apr 2025, 10:00 AM

The new entity will help to channelize the company’s antibiotic products across European Union
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback